Saturday, May 27, 2017
 
 
Company News: Page (1) of 1 - 05/16/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Theranos Finalizes Shareholder Recapitalization

(May 16, 2017)

Transaction unifies major investors around forward-looking business plans

PALO ALTO, Calif.--(BUSINESS WIRE)--Theranos, Inc. announced today the successful closing of an exchange offer designed to recapitalize its most recent investors. Holders of more than 99 percent of the shares eligible for the transaction elected to participate. Participants received new shares of the Companys preferred stock in exchange for their existing preferred stock. Theranos CEO Elizabeth Holmes contributed shares to the Company and gave up equity to offset potential dilution to non-participating shareholders. The transaction unifies the support of Theranos major investors as the Company moves toward commercializing its innovative technologies. All participating shareholders provided a release of any potential claims against the Company.

On May 1, Theranos announced the resolution of two lawsuits by Partner Fund Management LP (PFM), a hedge fund and investor in the Company. Last month, Theranos announced the resolution of all outstanding legal and regulatory proceedings between the Company and Centers for Medicare & Medicaid Services (CMS) and the resolution of all existing or potential claims by the Arizona Attorney General.

About Theranos


Founded in 2003 by Elizabeth Holmes, Theranos, Inc. is a health technology company headquartered in Palo Alto, Calif. Its proprietary miniLab platform is designed to enable earlier disease detection and intervention by facilitating low-cost small-sample collection, testing, and rapid communication of diagnostic information in distributed settings. To learn more about Theranos, visit www.theranos.com.


Contacts

Theranos, Inc.
Tali Mackay, 650-546-2321


Page: 1


Related Keywords:
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Silver Birch of Hammond Affordable Assisted Lifestyle Community Opens Doors
  • NetDirector Enables Next-Generation Integration in Radiology with American Health Imaging
  • APR Applied Pharma Research at the 9th ChinaBio® Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market
  • Medical Imaging Equipment Market Is Expected To Reach USD 44,887.4 Mn By 2022, Credence Research
  • Growth Opportunities in the Global Diagnostic Imaging Market, 2017-2022 - Research and Markets

    Cancer
  • Cone beam computed tomography (CBCT) Systems Market Expected to Reach $1,041 Million, Globally, by 2023 - Allied Market Research
  • Mesothelioma Compensation Center Now Urges the Family of a Person Who Recently Died From Mesothelioma Before They Could Hire a Lawyer to File a Claim to Call for Instant Help
  • Mapi Research Trust Unveils New Clinical Outcome Assessments (COA) Website for the Zarit Burden Interview (ZBI) Questionnaire
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010 - 2017: Deal trends, players, financials and forecasts
  • Artificial Intelligence Firm Set to Revolutionize Healthcare
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines